Skip to content

Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery

Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04282239
Enrollment
0
Registered
2020-02-24
Start date
2021-03-01
Completion date
2022-07-31
Last updated
2021-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative, Cardiac Surgery

Brief summary

The primary objective of this study is to determine if the addition of PECS2 block provides superior post-operative analgesia for cardiac surgery patients after midline sternotomy compared to only standard-of-care post-operative pain medication.

Detailed description

The current study is a prospective, double-blind study investigating the use of pectoral nerves (PECS) block 2 to alleviate post-operative pain in cardiac surgery patients. The investigators anticipate enrolling a total of 220 participants in one of two groups, an interventional PECS block group and a control group not receiving the block. The intervention will occur in the operating room after the completion of the cardiac procedure and prior to the transfer of the participants to the cardiothoracic intensive care unit (CTICU). Both groups will receive the standard-of-care (SOC) pain regimen; the intervention with receive the PECS block in addition to SOC pain regimen. The procedure takes approximately five to ten minutes and will be conducted by the attending cardiac anesthesiologist. Pain will then be monitored hourly in the post-operative period in the CTICU. Additional measures will be investigated that are regularly logged in the electronic medical record.

Interventions

PROCEDUREPECS2 block

Superficial peripheral nerve block placed at the interfascial plane between the pectoralis major and minor muscles and the plane between the pectoralis minor and serrates anterior muscles. Targeted nerves include the lateral and medial pectoral nerves in addition to the long thoracic nerve, thoracodorsal, and thoracic intercostal nerves from T2 to T6.

DRUGRopivacaine 0.5% Injectable Solution

15 mL on each side of anterior chest for a total of 30mL

10 mL on each side of anterior chest for a total of 20mL

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double-blind

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Obtaining one or more of the following elective surgical procedures at NYU Winthrop Hospital with midline sternotomy: * Coronary artery bypass graft (any number of vessels) * Aortic Valve Replacement (AVR) * Aortic Valve Repair * Mitral Valve Replacement (MVR) * Mitral Valve Repair * Tricuspid Valve Replacement * Tricuspid Valve Repair * Pulmonic Valve replacement * Pulmonic Valve Repair * Congenital Heart Defect Repair * Ascending Thoracic Aortic Aneurism Repair * Patient Age \> 18 years. 2. Willingness and ability to participate in the study procedures 3. Sufficiently hemodynamically stable to give consent

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study: * Hemodynamic instability * Preexisting infection at site of block * Allergy to block agents * Severe psychiatric illness * Intubated emergently prior to reception by the perioperative team * Patient is preoperatively on extracorporeal membrane oxygenation (ECMO) treatment. * Pregnant patient * Recent surgery

Design outcomes

Primary

MeasureTime frameDescription
Score on Critical-Care Pain Assessment Tool (CPOT)24 hoursMeasured at least hourly prior to extubation. This is an 8-item pain inventory seen as one of the top modalities for measuring pain in critical care patients. Minimum score of 0 and a maximum score of 8 (higher score = higher pain level).
Score on Visual Analog Scale (VAS)24 hoursMeasured at least hourly after extubation. 10 point pain analog scale (0-10, where 0 is no pain and 10 is highest pain level)

Secondary

MeasureTime frameDescription
Duration of operating room time5-7 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time scale with the time of 0 corresponding to the into operating room time and the final time being the out of operating room time
Total intraoperative fentanyl doseIntraoperative durationDocumented by anesthesia physician as standard of care - will be retrieved in the EMR. The scale is an absolute dosing scale in grams. It will be corrected for by weight (kilograms).
Duration of ICU stay24-48 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero is out of operating time and end time is time of downgrade or discharge from the hospital.
Duration of hospital stay5-7 days post-operativeDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time with time zero corresponding to admission to hospital time and end time being the time of discharge from the hospital.
Time to first opiate dose for breakthrough pain24-48 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero will be out of operating room time and end time will be time of administration of first opiate pain medication.
Ventilatory duration post-operatively0-6 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is a time scale with the time of 0 corresponding to the out of operating room time and the final time being the time period from the 0 time to the time when the patient is extubated.
Number of episodes of post-operative breakthrough pain24-48 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is an absolute number documenting the number of documented episodes of breakthrough pain.
Total post-operative opiate dose5-7 days post-operativeDocumented by registered nurse as standard of care - will be retrieved in the EMR. The scale is an absolute dosing scale in grams. It will be corrected for by weight (kilograms).
Score on Critical-Care Pain Assessment Tool (CPOT) at 24-48h24-48 hoursThis is an 8-item pain inventory seen as one of the top modalities for measuring pain in critical care patients. Minimum score of 0 and a maximum score of 8 (higher score = higher pain level). Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR
Score on Visual Analog Scale (VAS) at 24-48h24-48 hours10 point pain analog scale (0-10, where 0 is no pain and 10 is highest pain level) Documented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR
Number of adverse events related to safety of the nerve block5-7 days post-operativeAdverse events including but not limited to hemodynamic instability, respiratory depression, allergic reaction, shivering.
Time to first analgesic post-operatively24-48 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR. The scale is time. Time zero will be out of operating room time and end time will be time of administration of first breakthrough pain medication.
Duration of surgery4-6 hoursDocumented by nursing, physician assistants, physician, and/or respiratory staff as standard of care - will be retrieved in the EMR (Electronic Medical Records). The scale is a time scale with the time of 0 corresponding to the first incision time and the final time being the time period from the 0 time to the time when the PECS2 block is completed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026